Skip to main content
. 2019 Dec 2;8(1):27–33. doi: 10.1016/j.prnil.2019.10.005

Fig. 1.

Fig. 1

Waterfall plot of maximal percent changes in the value of prostate-specific antigen from the baseline in 55 Japanese patients with castration-resistant prostate cancer who received cabazitaxel.